SEC Filing Analysis: BIOLARGO, INC. (BLGO)

Executive Summary

• Trading Significance: Low
• Key Takeaway: The President and Director, Dennis P. Calvert, received 310,269 shares, valued at approximately $49,643, as a non-cash transaction to settle outstanding salary and business expenses.
• Market Impact: Neutral, due to the low value and non-cash nature of the transaction.

Company Information

Field	Value
Company	BIOLARGO, INC.
Ticker Symbol	BLGO
CIK	0000880242
Industry	Chemicals & Allied Products

Insider Information

Field	Value
Name	CALVERT DENNIS P
CIK	0001228572
Title/Position	President
Relationship	Director, Officer

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-11-14
Transaction Code	A
Security Type	Common Stock
Shares Involved	310,269
Price Per Share	$0.16
Total Value	$49,643.04
Shares Owned After	10,393,403
Ownership Type	Direct

Financial Impact Assessment

Impact Evaluation

• Transaction Nature: This is not an open-market purchase, which would signal direct insider confidence. Instead, it is an acquisition of equity in lieu of cash payment for salary and expenses. This is often done by companies to preserve cash.
• Ownership Concentration: The transaction increases the President's direct and indirect holdings to 10,393,403 shares. Without market capitalization or shares outstanding data, the percentage of ownership cannot be determined.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The transaction is small in absolute dollar value and represents compensation rather than a new investment decision by the insider. It is unlikely to materially influence market perception.

Volume & Sentiment

• Expected Volume Impact: Negligible. This type of filing typically does not drive significant trading volume.
• Sentiment Indicator: Neutral. The filing confirms the insider's continued involvement but does not provide a strong bullish or bearish signal.

Additional Context

Transaction Notes

• Special Circumstances: Per Footnote 2, the shares were received "in exchange for a reduction in amounts owed by Issuer to Reporting Person for salary and unreimbursed business expenses."
• Lock-Up Agreement: Per Footnote 1, the shares are subject to a lock-up agreement and are restricted from sale until the company achieves specific revenue or market capitalization milestones, or a change of control occurs.